Next report date
Report period
Q3 2024
EPS estimate
−1.49USD
Revenue estimate
37.50 KUSD
2.98USD
−31.84 MUSD
48.82 MUSD
6.15 M
About MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT)
Sector
CEO
David M. Urso
Headquarters
San Diego
Website
Employees (FY)
46
Founded
2000
FIGI
BBG00JVXDDL5
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.
MEIP LongAnalysis of the MEIP instrument and the possibility of its future movement relative to price ranges.
MEIP BullishThe most recent candle closed above the .5 fib level and the MACD just crossed to the bullish side.
Friday's candle also tested the descending trend line. Looking for a close above the upper trend line to open a swing position.
Targeting: $3.19, $3.37, $3.52 in the short term.
Choppy chop chop down?Choppy price action. Broke out from the descending triangle but little volume thus the retracement back to the key s/r neckline. Three-point of confirmation above 4H support could be broken if volume does not pick up.
Not financial advice
MEIP Break OutMACD is curling up for a cross and the 9ema is crossing the 20ema. Last candle showed strength and closed just bellow the 50% fibonacci level which is resistance. Looking for a break of $3.90
Short term target $4.58
MEIP - Wedge BreakoutMEI Pharma
Possible wedge breakout
MEI Pharma is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Its drug candidates include Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid le
Both its technical analysis and fundamental reports look great. Both its technical analysis and fundamental reports look great. This is a perfect time to buy this stock.
MEIP Possible Bull RunRecent price action formed a Daily Pin Bar off historical horizontal support and trend line. There is also Bullish Divergence with respect price and STOCHRSI. The 50% FIB ($2.60) just above current price demonstrated it is respected as price sat on it for a bit. The confluence of horizontal and tren
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0JW9 is 3.24 USD — it has decreased by 6.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) stocks are traded under the ticker 0JW9.
MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
0JW9 stock is 6.56% volatile and has beta coefficient of −0.72. Check out the list of the most volatile stocks — is MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) there?
0JW9 earnings for the last quarter are 8.46 USD per share, whereas the estimation was −1.80 USD resulting in a 571.31% surprise. The estimated earnings for the next quarter are −1.41 USD per share. See more details about MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) earnings.
Yes, you can track MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
0JW9 stock has fallen by 6.16% compared to the previous week, the month change is a 13.82% fall, over the last year MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) has showed a 32.76% decrease.
0JW9 net income for the last quarter is −11.06 M USD, while the quarter before that showed 56.37 M USD of net income which accounts for −119.62% change. Track more MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) financial stats to get the full picture.
Like other stocks, 0JW9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 46.00 employees. See our rating of the largest employees — is MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) stock shows the sell signal. See more of MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) future price: according to them, 0JW9 price has a max estimate of 42.00 USD and a min estimate of 7.00 USD. Read a more detailed MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) forecast: see what analysts think of MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) EBITDA is 17.35 M USD, and current EBITDA margin is −64.22%. See more stats in MEI PHARMA INC COM USD0.00000002 (POST REV SPLIT) financial statements.